Levetiracetam Tablet, Film Coated
Product Images NDC 70518-1772

14 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 70518-1772). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (24fe2e98 0b9f 4eea A745 E26002329cec 01)

Figure 1 (24fe2e98 0b9f 4eea A745 E26002329cec 01)
A formula panel showing how to calculate total daily dose in mL/day for Levetiracetam: Daily dose (mg/kg/day) multiplied by patient weight (kg), divided by the concentration 100 mg/mL.*
FDA Label Image

Figure 2 (24fe2e98 0b9f 4eea A745 E26002329cec 02)

Figure 2 (24fe2e98 0b9f 4eea A745 E26002329cec 02)
A text panel showing formulas for calculating creatinine clearance (CLcr), including age, weight, serum creatinine, and adjustments for female patients and body surface area (BSA). The equations provide the method to adjust CLcr values based on patient-specific parameters.*
FDA Label Image

Structure (24fe2e98 0b9f 4eea A745 E26002329cec 03)

Structure (24fe2e98 0b9f 4eea A745 E26002329cec 03)
Chemical structure of levetiracetam, showing its molecular arrangement including a pyrrolidone ring, an amide group, and an ethyl side chain.*
FDA Label Image

Figure 4 (24fe2e98 0b9f 4eea A745 E26002329cec 04)

Figure 4 (24fe2e98 0b9f 4eea A745 E26002329cec 04)
A vertical bar chart comparing the percentage of patients in three groups: Placebo (7.4%), Levetiracetam 1000 mg/day (37.1%), and Levetiracetam 3000 mg/day (39.6%). The x-axis labels the treatment groups with sample sizes, and the y-axis shows the percentage of patients, ranging from 0% to 45%. Asterisks appear above the Levetiracetam bars.*
FDA Label Image

Figure 5 (24fe2e98 0b9f 4eea A745 E26002329cec 05)

Figure 5 (24fe2e98 0b9f 4eea A745 E26002329cec 05)
A bar chart showing the percentage of patients responding to placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. The x-axis labels include placebo and two Levetiracetam dosage groups; the y-axis shows the percentage of patients from 0% to 45%. The chart indicates increasing patient percentages with higher Levetiracetam doses compared to placebo.*
FDA Label Image

Figure 6 (24fe2e98 0b9f 4eea A745 E26002329cec 06)

Figure 6 (24fe2e98 0b9f 4eea A745 E26002329cec 06)
Bar chart comparing the percentage of patients responding to placebo versus Levetiracetam 3000 mg/day. The placebo group (N=104) shows a response rate of 14.4%, while the Levetiracetam group (N=180) has a response rate of 39.4%, with an asterisk indicating statistical significance.*
FDA Label Image

Figure 7 (24fe2e98 0b9f 4eea A745 E26002329cec 07)

Figure 7 (24fe2e98 0b9f 4eea A745 E26002329cec 07)
A bar chart comparing the percentage of patients for Placebo (N=97) and Levetiracetam (N=101). The Levetiracetam group shows a higher percentage at 44.6%, while the Placebo group shows 19.6%. The vertical axis represents the percentage of patients, ranging from 0% to 45%.*
FDA Label Image

Figure 8 (24fe2e98 0b9f 4eea A745 E26002329cec 08)

Figure 8 (24fe2e98 0b9f 4eea A745 E26002329cec 08)
A bar chart comparing the percentage of patients between two groups: Placebo (N=51) and Levetiracetam (N=58). The y-axis represents the percentage of patients from 0% to 45%. The Placebo group shows 19.6%, and the Levetiracetam group shows 43.1%, indicating a higher percentage in the Levetiracetam group.*
FDA Label Image

Figure 9 (24fe2e98 0b9f 4eea A745 E26002329cec 09)

Figure 9 (24fe2e98 0b9f 4eea A745 E26002329cec 09)
A bar chart comparing the percentage of patients in two groups: Placebo (N=84) with 45.2% and Levetiracetam (N=79) with 72.2%. The y-axis represents the percentage of patients from 0% to 100%. Asterisk is shown above the Levetiracetam bar.*
FDA Label Image

Image (D1c36ef8 B1ae 459b B232 Dec8100baf09 615 1)

Image (D1c36ef8 B1ae 459b B232 Dec8100baf09 615 1)
Levetiracetam 500 mg film-coated tablets packaging label. The image shows a white bottle with a black and white patterned floral design near the bottom and side, without visible text details. The label indicates the product is from RemedyRepack Inc.*
FDA Label Image

Image (D1c36ef8 B1ae 459b B232 Dec8100baf09 638 1)

Image (D1c36ef8 B1ae 459b B232 Dec8100baf09 638 1)
Levetiracetam 500 mg film-coated tablets packaging label by RemedyRepack Inc. The image shows a white rectangular carton with the product name and strength visible, designed for oral administration. The package features a distinctive black flower or leaf pattern arranged vertically along one side.*
FDA Label Image

Mm1 (Levetiracetam 500mg 70518 1772 00)

Mm1 (Levetiracetam 500mg 70518 1772 00)
Levetiracetam Tablet 500 mg film-coated oral tablets, package contains 30 tablets. The label includes NDC 70518-1772-00 and is repackaged by RemedyRepack Inc., Indiana, PA. Manufacturer is Lupin Pharma, Baltimore, MD. Storage instructions and usual dosage reference to insert are noted.*
FDA Label Image

Mm2 (Levetiracetam 500mg 70518 1772 01)

Mm2 (Levetiracetam 500mg 70518 1772 01)
Levetiracetam 500 mg film-coated tablet label displaying the product name, strength, and quantity of 60 tablets. The label indicates the medication is prescription-only and repackaged by RemedyRepack Inc. It includes storage instructions and manufacturer information, Lupin Pharma, Baltimore, MD.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Levetiracetam 500 mg film-coated tablets packaging label showing quantity of 30 tablets. The label includes the RemedyRepack Inc. logo, NDC number 70518-1772-00, manufacturer Lupin Pharma in Baltimore, MD, and storage instructions. The label also indicates the product is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.